Recent 8-K filings for CRAC
Highest-materiality recent filing
Crown Reserve SPAC announces $1.0B business combination with Carvix
- Transaction values Carvix at $1.0B implied enterprise value; all-stock at $10.00/share reference price.
- Minimum $80M PIPE plus $20M committed equity line; requires $10M cash post-redemptions at close.
-
Crown Reserve (CRAC) enters definitive business combination with Carvix
SPAC merges with Carvix via domestication to Delaware; Carvix management team continues leading combined company.
-
Crown Reserve SPAC announces $1.0B business combination with Carvix
Transaction values Carvix at $1.0B implied enterprise value; all-stock at $10.00/share reference price.
-
Crown Reserve Acquisition announces separate trading of shares, warrants, rights from Dec 9, 2025
Holders of CRACU units may elect to separate into Class A shares (CRAC), warrants (CRACW), and rights (CRACR) starting Dec 9, 2025.
-
Crown Reserve Acquisition Corp. I closes $172.5M SPAC IPO on Nasdaq
Priced 17.25M units at $10/unit; gross proceeds $172.5M including full exercise of over-allotment.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.68 · Most common event m_and_a